Abstract:Background Visceral hypersensitivity is a common symptom in patients with post-infectious irritable bowel syndrome (PI-IBS), and change of the microbiota is a vital etiological factor of it. Clostridium butyricum (C. butyricum) is one of the probiotics which is reported as the active components in the treatment of IBS, especially IBS with diarrhea. Citrobacter rodentium (C. rodentium) is an enteropathogenic bacteria which can produce self-limiting colitis in mice, which have been used to produce a PI-IBS-like mice model. Whether C. butyricum could influence the visceral hypersensitivity and gut microbiota of PI-IBS is still unknown. Our study aimed to examine whether the intervention of C. butyricum or antibiotics could affect the etiology of visceral hypersensitivity. Methods C57BL/6 male mice were gavaged with the C. rodentium to induce a infective colitis. The C. butyricum and antibiotic compound were used to intervene the infected mice 3 days later. A 9-day chronic water avoidance stress (WAS) process was implemented to help induce the visceral hypersensitivity. The abdominal withdrawal reflex (AWR) score was assayed to indicate the visceral hypersensitivity of different groups. On the 7th, 14th, and 30th days after infection, mice feces were collected and high-throughput sequencing was carried out to analyze their gut microbiota. Results Combined, the C. rodentium infection plus chronic stress (WAS) could induce the visceral hypersensitivity in mice. Treatment of the C. butyricum after C. rodentium infection could relieve visceral hypersensitivity of mice, while no difference was observed in the antibiotic treatment group. The gut microbiota diversity of C. rodentium infected mice was similar to the uninfected mice, while there were different microbial communities structure between them. The Shannon and Chao indexes significantly decreased in the antibiotic treatment group compared to other groups at 7th, 14th, and 30th days post-infection, while treatment of C. butyricum could maintain the indexes within normal range. At day 14 after infection, the structure of microbiota headed towards normality after the C. butyricum treatment. After the WAS, the Shannon and Chao indexes of the control group decreased and the structure of microbiota changed. The C. butyricum treatment could prevent these changes of the gut microbiota induced by WAS. Conclusion C. butyricum could relieve the visceral hypersensitivity in mice induced by C. rodentium infection plus chronic stress. It could also remodel the microbiota change caused by the infection and chronic stress. It may be a more effective treatment strategy for PI-IBS than antibiotics.

Fecal Microbiota Transplantation is Effective in Relieving Visceral Hypersensitivity in a Postinfectious Model

Low FODMAP Diet Relieves Visceral Hypersensitivity and is Associated with Changes in Colonic Microcirculation in Water Avoidance Mice Model.

Aggregation and Self-Assembly of Hydrophobins from Trichoderma Reesei: Low-Resolution Structural Models

Clostridium Butyricum Relieve the Visceral Hypersensitivity in Mice Induced by Citrobacter Rodentium Infection with Chronic Stress.

Treatment and mechanism of fecal microbiota transplantation in mice with experimentally induced ulcerative colitis

Effect of Coloclysis with Sodium Butyrate Solution on Visceral Perception in Rats

Fecal Microbiota Transplantation (FMT) Alleviates Experimental Colitis in Mice by Gut Microbiota Regulation

BIFIDOBACTERIUM LONGUM RELIEVES VISCERAL HYPERSENSITIVITY AND MICROBIOTA DYSBIOSIS BY REGULATING PANETH CELLS FUNCTIONS

Study on Effect of Probiotic Agents on Visceral Sensitivity in Rat Model with Visceral Hypersensitivity

The Evaluation of Fecal Microbiota Transplantation Vs Vancomycin in a Clostridioides Difficile Infection Model.

Bacteroides thetaiotaomicron and Faecalibacterium prausnitzii served as key components of fecal microbiota transplantation to alleviate colitis

Fecal microbiota transplantation ameliorates experimental colitis via gut microbiota and T-cell modulation

Visceral Hypersensitive Rats Share Common Dysbiosis Features with Irritable Bowel Syndrome Patients.

Are There Any Different Effects of Bifidobacterium, Lactobacillus and Streptococcus on Intestinal Sensation, Barrier Function and Intestinal Immunity in PI-IBS Mouse Model?

Bifidobacterium longum regulates the visceral hypersensitivity of PI-IBS by inhibiting NLRP6 inflammasome

Beneficial Effects of Fecal Microbiota Transplantation on Ulcerative Colitis in Mice

Intestinal Inflammation Induces Visceral and Somatic Hypersensitivity

Effect of SB203580 on visceral hypersensitivity in the irritable bowel syndrome rats

Human Fecal Microbiota Transplantation Reduces the Susceptibility to Dextran Sulfate Sodium-Induced Germ-Free Mouse Colitis

Fecal Microbiota Transplantation Controls Murine Chronic Intestinal Inflammation by Modulating Immune Cell Functions and Gut Microbiota Composition

Whole intestinal microbiota transplantation is more effective than fecal microbiota transplantation in reducing the susceptibility of DSS-induced germ-free mice colitis